Jeffrey M. Rybak, Pharm.D., Ph.D.
Jeffrey M. Rybak, Pharm.D., Ph.D.
University of Tennessee College of Pharmacy
確認したメール アドレス: uthsc.edu
タイトル
引用先
引用先
Azole antifungal resistance in Candida albicans and emerging non-albicans Candida species
SG Whaley, EL Berkow, JM Rybak, AT Nishimoto, KS Barker, PD Rogers
Frontiers in microbiology 7, 2173, 2017
4492017
The β‐Lactams Strike Back: Ceftazidime‐Avibactam
EJ Zasowski, JM Rybak, MJ Rybak
Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 35 (8 …, 2015
1422015
Isavuconazole: pharmacology, pharmacodynamics, and current clinical experience with a new triazole antifungal agent
JM Rybak, KR Marx, AT Nishimoto, PD Rogers
Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 35 (11 …, 2015
722015
Oritavancin: a new lipoglycopeptide antibiotic in the treatment of Gram-positive infections
KD Brade, JM Rybak, MJ Rybak
Infectious diseases and therapy 5 (1), 1-15, 2016
642016
Tedizolid phosphate: a next-generation oxazolidinone
JM Rybak, K Roberts
Infectious diseases and therapy 4 (1), 1-14, 2015
642015
Abrogation of Triazole Resistance upon Deletion of CDR1 in a Clinical Isolate of Candida auris
JM Rybak, LA Doorley, AT Nishimoto, KS Barker, GE Palmer, PD Rogers
Antimicrobial agents and chemotherapy 63 (4), e00057-19, 2019
502019
Current and prospective treatments for multidrug-resistant gram-positive infections
JM Rybak, KE Barber, MJ Rybak
Expert opinion on pharmacotherapy 14 (14), 1919-1932, 2013
502013
Early experience with tedizolid: clinical efficacy, pharmacodynamics, and resistance
JM Rybak, K Marx, CA Martin
Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 34 (11 …, 2014
492014
Mutations in hmg1, Challenging the Paradigm of Clinical Triazole Resistance in Aspergillus fumigatus
JM Rybak, W Ge, NP Wiederhold, JE Parker, SL Kelly, PD Rogers, ...
MBio 10 (2), e00437-19, 2019
432019
Emerging threat of triazole-resistant Aspergillus fumigatus
JM Rybak, JR Fortwendel, PD Rogers
Journal of Antimicrobial Chemotherapy 74 (4), 835-842, 2019
262019
Loss of C-5 sterol desaturase activity results in increased resistance to azole and echinocandin antifungals in a clinical isolate of Candida parapsilosis
JM Rybak, CM Dickens, JE Parker, KE Caudle, K Manigaba, SG Whaley, ...
Antimicrobial agents and chemotherapy 61 (9), e00651-17, 2017
252017
Mutations in TAC1B: a Novel Genetic Determinant of Clinical Fluconazole Resistance in Candida auris
JM Rybak, JF Muñoz, KS Barker, JE Parker, BD Esquivel, EL Berkow, ...
MBio 11 (3), e00365-20, 2020
22*2020
Imipenem‐Cilastatin‐Relebactam: A Novel β‐Lactam–β‐Lactamase Inhibitor Combination for the Treatment of Multidrug‐Resistant Gram‐Negative Infections
JR Smith, JM Rybak, KC Claeys
Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 40 (4 …, 2020
222020
Pharmacokinetic and pharmacodynamic analyses of ceftaroline in adults with cystic fibrosis
EB Autry, JM Rybak, NR Leung, BM Gardner, DR Burgess, MI Anstead, ...
Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 36 (1 …, 2016
142016
Utilizing Monte Carlo simulations to optimize institutional empiric antipseudomonal therapy
SJ Tennant, DR Burgess, JM Rybak, CA Martin, DS Burgess
Antibiotics 4 (4), 643-652, 2015
112015
An azole-tolerant endosomal trafficking mutant of Candida albicans is susceptible to azole treatment in a mouse model of vaginal candidiasis
BM Peters, A Luna-Tapia, H Tournu, JM Rybak, PD Rogers, GE Palmer
Antimicrobial agents and chemotherapy 61 (6), e00084-17, 2017
92017
Mechanisms of triazole resistance in Aspergillus fumigatus
AV Nywening, JM Rybak, PD Rogers, JR Fortwendel
Environmental Microbiology 22 (12), 4934-4952, 2020
82020
Characterization of the efflux capability and substrate specificity of Aspergillus fumigatus PDR5-like ABC transporters expressed in Saccharomyces cerevisiae
BD Esquivel, JM Rybak, KS Barker, JR Fortwendel, PD Rogers, TC White
Mbio 11 (2), e00338-20, 2020
72020
Azole antifungal resistance in Candida albicans and emerging non-albicans Candida species. Front Microbiol. 2017; 7: 2173
SG Whaley, EL Berkow, JM Rybak, AT Nishimoto, KS Barker, PD Rogers
52016
Mutations in TAC1B: a novel genetic determinant of clinical fluconazole resistance in
JM Rybak, JF Muñoz, KS Barker, JE Parker, BD Esquivel, EL Berkow, ...
Candida auris, 2020
32020
現在システムで処理を実行できません。しばらくしてからもう一度お試しください。
論文 1–20